Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 129 clinical trials
Semi Occlusion of the Coronary Sinus as an Adjunct to PCI in STEMI Patients, FIH Clinical Study

The present study is planned to evaluate the safety and feasibility of the Booster Balloon catheter when applied to STEMI patients. The Booster Balloon is a spiral balloon intended to be

  • 0 views
  • 16 Oct, 2022
  • 2 locations
Intravascular Ultrasound Versus Angiography Guided Drug-coated Balloon Treatment for STEMI Patients a Prospective Multicenter Randomized Controlled Trial

angiography for ST-segment elevated myocardial infarction STEMIpatients. Background: In primary percutaneous coronary intervention for STEMI, DCB angioplasty has proved to be a safe and feasible

  • 0 views
  • 24 Jan, 2021
  • 1 location
Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI

This is a randomized, open label, cohort study, in which a total of 100 patients will be enrolled and randomly assigned to receive bivalirudin or heparin in a 1:1 ratio during short-term intervention of non-infarction related artery for acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention. NACE, MACE, …

  • 0 views
  • 09 May, 2022
  • 1 location
Thrombolysis in STEMI Patients Compared With pPCI on Recanalization Time in the Context of the COVID-19 Outbreak. (RESCUE-STEMI)

During the outbreak of COVID-19, for patients with acute ST-segment elevation myocardial infarction with unclear infection, the time of primary PCI is uncertain, and it is often expected to exceed 90 minutes or even 120 minutes. In indicated patients, intravenous thrombolysis has significantly improved the recanalization time of criminal vessels.

  • 0 views
  • 07 Jun, 2022
  • 1 location
Ticagrelor Monotherapy After Stenting (TIMO)

, prospective phase II study 200 patients who undergo coronary artery stenting due to NSTEMI or STEMI will be included. Primary endpoint (variable): The composite of cardiac death, spontaneous

  • 0 views
  • 30 Jun, 2022
  • 1 location
Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction

This is a multi-center, prospective, randomized, controlled study. The patients with STEMI who were to undergo PPCI were divided into PCSK9 inhibitor group (n=80) and conventional treatment

  • 0 views
  • 07 Oct, 2022
  • 4 locations
Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE

Objective: to evaluate the efficacy and safety of the Recombinant Non-immunogenic Staphylokinase with its single bolus administration in comparison with the bolus-infusion administration of the Alteplase in patients with massive pulmonary embolism

  • 0 views
  • 07 Oct, 2022
  • 14 locations
Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)

Patients with STEMI (ST-segment elevation myocardial infarction) with multivessel disease which have PCI (percutaneous coronary intervention)-suitable non-IRA (infarct related artery) will be

  • 0 views
  • 04 Oct, 2022
  • 19 locations
Intravascular Ultrasound Guided PCI in STEMI (iSTEMI)

The purpose of is study is to investigate whether intravascular ultrasound-guided (IVUS) percutaneous coronary intervention (PCI) improve the clinical outcome of patients with ST-segment elevation myocardial infarction treated with primary PCI.

chest pain
stemi
depression
percutaneous coronary intervention
left bundle branch block
  • 0 views
  • 18 Jun, 2022
  • 1 location
Thrombus Aspiration in STEMI Patients With High Thrombus Burden

This is a prospective, multicenter, open-label, randomized, controlled, parallel group study, in which ST-segment Elevation Myocardial Infarction (STEMI) patients with high thrombus burden(TIMI

stemi
percutaneous coronary intervention
clot
  • 0 views
  • 16 Mar, 2021
  • 50 locations